In USP <1790> it focuses on detecting and removing units of visible particles; in addition, it promotes the need of preventing particulate contamination—which only comes from identifying the particle. Most pharmaceuticals require an understanding of particulate matter contamination. The ability to identify and characterize a particle is extremely beneficial with improving products within the development…
Read more
Pfizer-BioNTech Vaccine Recall
With the click of a button, The Identifier System could have quickly tracked and traced the origin of the Pfizer-BioNTech vaccine defects and its distribution trail. On March 23, 2021, Hong Kong puts a stop on distributing the Pfizer-BioNTech Vaccine to residents. Many containers were flawed among a batch of 585,000 doses due to packaging…
Read more
What is a Recall?
About 4,500 drugs and devices are recalled yearly in the United States. Prior to these recalls, they were approved by the FDA, widely injected, implanted and ingested by customers. The FDA does not initiate a recall, they simply express concern and leave it up to the manufacture to execute a recall. The FDA can only…
Read more
Parenterals, Particulates, and Quality by Design
Particulate matter in parenteral drugs has been a known issue for over two centuries. Particular matter could come from any little thing that is involved in the process of making the drug product. Contaminants could come from the environment, packaging for the product, ingredients in the product, reactions of the formula and anything that could…
Read more